MORGANTOWN, W. Va., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”, “the Company”) announced today that Stephen Turner, CEO and Chairman, will be presenting at the Biotech Showcase™ 2016 Conference being held in San Francisco, CA January 11 - 13, 2016.
Turner will provide an update on Protea’s integrated proteomics-metabolomics technology platforms and commercial development, and will be available to participate in one-on-one meetings. Details of the Company’s presentation are as follows:
| Event: | Biotech Showcase™ 2016 Conference | |
| Date: | Tuesday, January 12, 2016 | |
| Time: | 4:30 PM Pacific Time | |
| Room Mission II Parc 55 Wyndham San Francisco Union Square Hotel |
About Protea Biosciences
Protea Biosciences Group, Inc. (OTCQB:PRGB) is a molecular information company providing innovative bio-analytical technology to the pharmaceutical and life science industries. "Molecular information" refers to the generation and bioinformatic processing of very large data sets, obtained by applying the Company's technology to identify and characterize the proteins, metabolites, lipids and other biomolecules which are the byproducts of all living cells and life forms.
About the Biotech Showcase™ 2016 Conference
Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry’s largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase is expected to attract upwards of 1,500 attendees.
For more Information:
Protea Biosciences Group, Inc., 1311 Pineview Dr., Morgantown, WV 26505 USA
Phone: 304.292.2226 Fax: 304.292.7101
https://proteabio.com/investors
Protea is a registered trademarks of Protea Biosciences Group, Inc.